Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 5/20 | 0.65 |
| ▸ | CES1 | P23141 | 5/20 | 0.65 |
| ▸ | FAAH | O00519 | 2/20 | 0.55 |
| ▸ | PPARG | P37231 | 6/20 | 0.50 |
| ▸ | PPARD | Q03181 | 6/20 | 0.50 |
| ▸ | PPARA | Q07869 | 6/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3187591 | 1.00 | CES2 (0.65) | CES2CES1FAAHPPARGPPARD | |
| SCHEMBL7640351 | 1.00 | CES2 (0.65) | CES2CES1FAAHPPARGPPARD | |
| SCHEMBL16007022 | 1.00 | CES2 (0.65) | CES2CES1FAAHPPARGPPARD | |
| SCHEMBL1088229 | 1.00 | CES2 (0.65) | CES2CES1FAAHPPARGPPARD | |
| SCHEMBL15708761 | 1.00 | CES2 (0.65) | CES2CES1FAAHPPARGPPARD | |
| SCHEMBL3188212 | 1.00 | CES2 (0.65) | CES2CES1FAAHPPARGPPARD | |
| SCHEMBL3009970 | 0.98 | CES2 (0.64) | CES2CES1FAAHPPARGPPARD | |
| SCHEMBL7614127 | 0.92 | HAO1 (0.58) | CES2CES1FAAHPPARGPPARD | |
| SCHEMBL910065 | 0.91 | CES1 (0.62) | CES2CES1FAAHHDAC11TSHR | |
| SCHEMBL16007053 | 0.89 | FAAH (0.73) | FAAHPPARGPPARDPPARAFABP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2096165-B1 | NOVEL ALCOHOL DEHYDROGENASE, GENE FOR THE ALCOHOL DEHYDROGENASE, VECTOR, TRANSFORMANT, AND METHOD FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOL BY USING THEM | KANEKA CORP (JP) | 2016-08-24 | — | — | EP | disclosed |
| US-20140256904-A1 | BIOTECHNOLOGICAL SYNTHESIS PROCESS OF OMEGA-FUNCTIONALIZED CARBON ACIDS AND CARBON ACID ESTERS FROM SIMPLE CARBON SOURCES | EVONIK DEGUSSA GMBH (DE) | 2014-09-11 | — | — | US | disclosed |
| US-8129163-B2 | Gene suitable for alcohol dehydrogenase, vector and transformant | KANEKA CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20100035317-A1 | NOVEL ALCOHOL DEHYDROGENASE, GENE FOR THE ALCOHOL DEHYDROGENASE, VECTOR, TRANSFORMANT, AND METHOD FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOL BY USING THEM | KANEKA CORPORATION (JP) | 2010-02-11 | — | — | US | disclosed |
| EP-2096165-A1 | NOVEL ALCOHOL DEHYDROGENASE, GENE FOR THE ALCOHOL DEHYDROGENASE, VECTOR, TRANSFORMANT, AND METHOD FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOL BY USING THEM | Kaneka Corporation (JP) | 2009-09-02 | — | — | EP | disclosed |
| US-20070060643-A1 | Autoinducer compounds | MONTANA STATE UNIVERSITY (US) | 2007-03-15 | — | — | US | disclosed |
| US-7078435-B2 | Autoinducer compounds | MONTANA STATE UNIVERSITY (US) | 2006-07-18 | — | — | US | disclosed |
| EP-1487269-A4 | AUTOINDUCER COMPOUNDS | UNIV MONTANA STATE (US) | 2005-12-21 | — | — | EP | disclosed |
| EP-1487269-A1 | AUTOINDUCER COMPOUNDS | Montana State University-Bozeman (US) | 2004-12-22 | — | — | EP | disclosed |
| US-20040254235-A1 | Autoinducer compounds | NATIONAL SCIENCE FOUNDATION | 2004-12-16 | — | — | US | disclosed |
| EP-1087957-A4 | AUTOINDUCER COMPOUNDS | UNIV MONTANA RES DEV INST (US) | 2003-01-02 | — | — | EP | disclosed |
| US-6348617-B1 | REACTING PYRUVIC ACID COMPOUND IN WATER WITH AMMONIUM OR ALKALI METAL BISULFITE TO GIVE AQUEOUS SOLUTION OF BISULFITE ADDUCT, ISOLATING BY PHASE SEPARATION, OPTIONALLY USING HYDROPHOBIC SOLVENT, CONTACTING WITH ACID TO DECOMPOSE ADDUCT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-02-19 | — | — | US | disclosed |
| US-6337347-B1 | ENHANCE GENE EXPRESSION IN A WIDE VARIETY OF MICROORGANISMS, THERAPEUTIC COMPOSITIONS AND THERAPEUTIC METHODS WHEREIN GENE EXPRESSION WITHIN MICROORGANISMS IS REGULATED ARE DISCLOSED. | THE RESEARCH & DEVELOPMENT INSTITUTE, INC. | 2002-01-08 | — | — | US | disclosed |
| EP-0818452-B1 | Preparation of cis-isoambrettolides and their use as a fragrance | MANE V FILS SA (FR) | 2001-10-24 | — | — | EP | disclosed |
| EP-1087957-A1 | AUTOINDUCER COMPOUNDS | THE RESEARCH AND DEVELOPMENT INSTITUTE, INC (US) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999065889-A1 | AUTOINDUCER COMPOUNDS | THE RESEARCH AND DEVELOPMENT INSTITUTE (US) | 1999-12-23 | — | — | WO | disclosed |
| EP-0937703-A1 | METHOD FOR PURIFYING PYRUVIC ACID COMPOUNDS | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1999-08-25 | — | — | EP | disclosed |
| US-5786321-A | Preparation of cis-isoambrettolidies and their use as a fragrance | V. MANE FILS S.A. (FR) | 1998-07-28 | — | — | US | disclosed |
| US-5726328-A | Preparation of cis-isoambrettolides and their use as a fragrance | V. MANE FILS S.A. (FR) | 1998-03-10 | — | — | US | disclosed |
| EP-0818452-A2 | Preparation of cis-isoambrettolides and their use as a fragrance | V. Mane Fils S.A. (FR) | 1998-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254235-A1 | Autoinducer compounds | MYC, BLVRB, MRPL21 | CES2 2715/4885CES1 2168/4885FAAH 1498/4885 |
| US-20070060643-A1 | Autoinducer compounds | MYC, BLVRB, MRPL21 | CES2 2715/4885CES1 2168/4885FAAH 1498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.